MAM
TRML

Marquette Asset Management’s Tourmaline Bio TRML Stock Holding History

Marquette Asset Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,003
Closed -$112K – 293
2023
Q3 		$112K Sell
4,003
-6,135
-61% -$180K 0.03% 97
2023
Q2 		$308K Hold
10,138
– – 0.08% 63
2023
Q1 		$191K Buy
10,138
+2,200
+28% +$36.3K 0.05% 84
2022
Q4 		$81K Buy
+7,938
New +$128K 0.02% 122

Other funds holding TRML

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Marquette Asset Management's TRML Position: Q4 2023 in Review

Marquette Asset Management sold out of Tourmaline Bio (TRML) in Q4 2023, closing a stake of 4,003 shares — an estimated $112K sold.

Marquette Asset Management first reported a position in TRML in Q4 2022 and held it in 4 quarters. The position peaked at $308K in Q2 2023. 54 funds tracked by Wall St. Rank hold TRML as of Q4 2023.

  • Marquette Asset Management reported no remaining Tourmaline Bio position as of Q4 2023 after selling out during the quarter.
  • Marquette Asset Management sold 4,003 Tourmaline Bio shares in Q4 2023, an estimated $112K.
  • Marquette Asset Management first reported a position in Tourmaline Bio in Q4 2022 and held it in 4 quarters.
  • Marquette Asset Management's Tourmaline Bio position peaked at $308K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2023.

Based on Marquette Asset Management's 13F filing for Q4 2023, filed 2 Feb 2024.